SIRT5 facilitates cancer cell growth and drug resistance in non-small cell lung cancer

[1]  Shun Lu,et al.  The histone acetylranseferase hMOF acetylates Nrf2 and regulates anti‐drug responses in human non‐small cell lung cancer , 2014, British journal of pharmacology.

[2]  Matthew J. Rardin,et al.  SIRT5 regulates the mitochondrial lysine succinylome and metabolic networks. , 2013, Cell metabolism.

[3]  D. Dai,et al.  Sirt2 suppresses glioma cell growth through targeting NF-κB-miR-21 axis. , 2013, Biochemical and biophysical research communications.

[4]  Yingming Zhao,et al.  SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways. , 2013, Molecular cell.

[5]  Xiaoling Xu,et al.  SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism. , 2013, Cancer cell.

[6]  Yasuhiko Nakamura,et al.  SIRT5 deacetylates and activates urate oxidase in liver mitochondria of mice , 2012, FEBS letters.

[7]  I. Torres-Aleman,et al.  The many faces of insulin-like peptide signalling in the brain , 2012, Nature Reviews Neuroscience.

[8]  Johan Auwerx,et al.  Sirtuins as regulators of metabolism and healthspan , 2012, Nature Reviews Molecular Cell Biology.

[9]  J. Boeke,et al.  Lysine Succinylation and Lysine Malonylation in Histones* , 2012, Molecular & Cellular Proteomics.

[10]  Johan Auwerx,et al.  Sirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase , 2011, Science.

[11]  M. Kruszewski,et al.  Molecular cross-talk between the NRF2/KEAP1 signaling pathway, autophagy, and apoptosis. , 2011, Free radical biology & medicine.

[12]  Zhihong Zhang,et al.  Identification of lysine succinylation as a new post-translational modification. , 2011, Nature chemical biology.

[13]  S. Biswal,et al.  Gain of Nrf2 function in non-small-cell lung cancer cells confers radioresistance. , 2010, Antioxidants & redox signaling.

[14]  Donna D. Zhang.  The Nrf2-Keap1-ARE signaling pathway: The regulation and dual function of Nrf2 in cancer. , 2010, Antioxidants & redox signaling.

[15]  N. Rothman,et al.  Mitochondrial DNA copy number and lung cancer risk in a prospective cohort study. , 2010, Carcinogenesis.

[16]  N. Kikuchi,et al.  Nrf2 Enhances Cell Proliferation and Resistance to Anticancer Drugs in Human Lung Cancer , 2009, Clinical Cancer Research.

[17]  Takashi Nakagawa,et al.  SIRT5 Deacetylates Carbamoyl Phosphate Synthetase 1 and Regulates the Urea Cycle , 2009, Cell.

[18]  C. Reynolds,et al.  Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy , 2009, Clinical Cancer Research.

[19]  S. Hirohashi,et al.  Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. , 2008, Cancer research.

[20]  N. Inagaki,et al.  Localization of mouse mitochondrial SIRT proteins: shift of SIRT3 to nucleus by co-expression with SIRT5. , 2008, Biochemical and biophysical research communications.

[21]  Lu Li,et al.  Downregulation of Sirt1 by antisense oligonucleotides induces apoptosis and enhances radiation sensitization in A549 lung cancer cells. , 2007, Lung cancer.

[22]  S. Awasthi,et al.  Therapeutic resistance in lung cancer , 2006, Expert opinion on drug metabolism & toxicology.

[23]  J. Herman,et al.  Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer , 2006, PLoS medicine.

[24]  Tsutomu Ohta,et al.  Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. , 2006, Molecular cell.

[25]  A. Jaiswal,et al.  Nrf2 signaling in coordinated activation of antioxidant gene expression. , 2004, Free radical biology & medicine.

[26]  Mitsuhiro Osame,et al.  Mitochondrial DNA mutation correlates with stage progression and prognosis in non‐small cell lung cancer , 2003, Human mutation.

[27]  G. Peters,et al.  Chemotherapy triggers apoptosis in a caspase-8-dependent and mitochondria-controlled manner in the non-small cell lung cancer cell line NCI-H460. , 2000, Cancer research.

[28]  J. Jen,et al.  Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. , 2000, Science.